- Home
- RCUS vs LION Comparison
RCUS vs LION Comparison
Compare RCUS & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | LION |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.5B |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | RCUS | LION |
|---|---|---|
| Price | $28.92 | $13.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $31.90 | $11.89 |
| AVG Volume (30 Days) | 1.6M | ★ 3.2M |
| Earning Date | 05-05-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $247,000,000.00 | ★ $2,631,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.62 | $22.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.84 | $5.65 |
| 52 Week High | $31.74 | $16.70 |
Technical Indicators
Market Signals| Indicator | RCUS | LION |
|---|---|---|
| Relative Strength Index (RSI) | 56.87 | 40.33 |
| Support Level | $22.79 | $13.19 |
| Resistance Level | $31.74 | $15.01 |
| Average True Range (ATR) | 1.72 | 0.59 |
| MACD | -0.01 | -0.32 |
| Stochastic Oscillator | 62.14 | 4.62 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About LION Lionsgate Studios Corp.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.